Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
12/23/1999 | WO1999066031A2 Pharmaceutical factor vii preparation |
12/23/1999 | WO1999065930A1 Vitamin b12 derivatives and methods for their preparation |
12/23/1999 | WO1999065599A1 Flowable preparations of the water-in-oil emulsion type having an increased water content |
12/23/1999 | WO1999065598A1 Flowable preparations of the water-in-oil emulsion type having an increased water content |
12/23/1999 | WO1999065540A2 Medical infusion device with a source of controlled compliance |
12/23/1999 | WO1999065539A2 Tumescent solution |
12/23/1999 | WO1999065538A1 Medical device having anti-infective and contraceptive properties |
12/23/1999 | WO1999065532A1 Method and device for delivery of therapeutic agents in conjuction with isotope seed placement |
12/23/1999 | WO1999065531A1 Polymers for delivery of nucleic acids |
12/23/1999 | WO1999065527A1 Solution comprising prostaglandins and benzyl alcohol |
12/23/1999 | WO1999065526A1 Topical ointment composition for burn treatment |
12/23/1999 | WO1999065505A1 Oregano for the treatment of internal parasites and protozoa |
12/23/1999 | WO1999065499A1 Cyclophosphamide coated tablets |
12/23/1999 | WO1999065498A1 Agents for relieving side effects of adrenal cortex hormone |
12/23/1999 | WO1999065497A1 Vaginal active agent delivery procedures and formulations thereof |
12/23/1999 | WO1999065496A1 Pharmaceutical tablets comprising an nsaid and a prostaglandin |
12/23/1999 | WO1999065493A1 Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects |
12/23/1999 | WO1999065491A1 Method of treatment |
12/23/1999 | WO1999065481A1 Liposomal formulations of busulphan |
12/23/1999 | WO1999065473A1 Process for forming chewable quickly dispersing multi-vitamin preparation and product therefrom |
12/23/1999 | WO1999065472A1 Method for manufacturing a laminate consisting of individual layers |
12/23/1999 | WO1999065471A1 Method for making tablets with active principle sustained-release |
12/23/1999 | WO1999065470A1 Particulate acellular tissue matrix |
12/23/1999 | WO1999065469A2 Processes to generate submicron particles of water-insoluble compounds |
12/23/1999 | WO1999065467A1 Method for introducing a chemical agent into the systemic circulation |
12/23/1999 | WO1999065466A1 Temperature-sensitive liposomal formulation |
12/23/1999 | WO1999065465A1 Method of forming liposomes |
12/23/1999 | WO1999065464A1 Pharmaceutical formulations for aerosols with two or more active substances |
12/23/1999 | WO1999065463A1 Active ingredient delivery systems and devices based on porous matrices |
12/23/1999 | WO1999065461A2 Cationic amphiphile micellar complexes |
12/23/1999 | WO1999065460A2 Pressurized metered dose inhalers and pharmaceutical aerosol formulations comprising a beta-agonist |
12/23/1999 | WO1999065456A1 Foaming composition for hair care |
12/23/1999 | WO1999065454A1 Hydrous cosmetic or pharmaceutical sticks |
12/23/1999 | WO1999065452A2 Hydrogels of water soluble polymers crosslinked by protein domains |
12/23/1999 | WO1999065448A2 Cosmetic or dermopharmaceutical composition in the form of beads and methods for preparing same |
12/23/1999 | WO1999065430A1 Adhesively applied external nasal strips and dilators containing medications and fragrances |
12/23/1999 | WO1999065316A1 Stabilized mixtures of an iodopropargyl compound and a formaldehyde donor |
12/23/1999 | WO1999065303A1 Composition and method for treating penile erectile dysfunction |
12/23/1999 | WO1999053904A3 Softgel-compatible composition containing retinol |
12/23/1999 | WO1999051629A3 New compounds for dna-transfection |
12/23/1999 | WO1999033859A3 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
12/23/1999 | WO1996001622A8 New oral pharmaceutical formulation containing magnesium salt of omeprazole |
12/23/1999 | DE19828881A1 Industrial preparation of prostane derivatives, especially iloprost, having reduced content of decomposition products |
12/23/1999 | DE19827732A1 Transdermal patch useful for hormone replacement therapy used for treatment of menopausal symptoms |
12/23/1999 | DE19827122A1 Volatilization of medicinal ointments and creams for e.g. colds and chills |
12/23/1999 | DE19826793A1 Stable diminazene diaceturate preparation having antiprotozoal activity, used e.g. for treating malaria or trypanosomiasis |
12/23/1999 | CA2335638A1 Cationic amphiphile micellar complexes |
12/23/1999 | CA2335460A1 Polymers for delivery of nucleic acids |
12/23/1999 | CA2335361A1 Medicament for reducing side effects of adrenocortical hormones |
12/23/1999 | CA2335303A1 Pressurized metered dose inhalers and pharmaceutical aerosol formulations |
12/23/1999 | CA2335255A1 Vaginal active agent delivery procedures and formulations thereof |
12/23/1999 | CA2335236A1 Method of treatment |
12/23/1999 | CA2335183A1 Method of forming liposomes |
12/23/1999 | CA2335055A1 Medical device having anti-infective and contraceptive properties |
12/23/1999 | CA2334996A1 Active ingredient delivery systems and devices based on porous matrices |
12/23/1999 | CA2334598A1 Vitamin b12 derivatives and methods for their preparation |
12/23/1999 | CA2300892A1 Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects |
12/22/1999 | EP0965626A1 Hydrophilic adhesive masses |
12/22/1999 | EP0965623A1 Stabilized monomer adhesive compositions |
12/22/1999 | EP0965351A2 Pharmaceutical composition for treating side-effects of a diet with reduced amount of carbohydrates |
12/22/1999 | EP0965344A1 Prophylactic and therapeutic agent for inflammatory intestinal diseases |
12/22/1999 | EP0965343A2 Ziprasidone formulations |
12/22/1999 | EP0965342A1 Preparation for percutaneous administration |
12/22/1999 | EP0965339A1 Tabletted preparation |
12/22/1999 | EP0965338A1 Low oxygen content perfluoroalkanes for ophthalmologic use |
12/22/1999 | EP0965337A1 Method to produce devices for controlled drug release |
12/22/1999 | EP0965336A1 Microencapsulated DNA for gene therapy |
12/22/1999 | EP0965335A1 Metered-dose aerosol formulations |
12/22/1999 | EP0965334A1 Liquid respiratory product for intubation |
12/22/1999 | EP0965332A2 Blackhead removing agent, blackhead removing sheet, and method for producing blackhead removing sheet |
12/22/1999 | EP0965330A1 Cosmetic and dermatolic compositions containing chitosan and phospholipids |
12/22/1999 | EP0965329A1 Skin treatment agents and use thereof for preparing dermatological compositions |
12/22/1999 | EP0965278A1 Dietetic food composition and dietetic method using such composition |
12/22/1999 | EP0964846A2 Process for preparing aromatic polyamine mixtures |
12/22/1999 | EP0964698A1 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine |
12/22/1999 | EP0964690A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
12/22/1999 | EP0964680A1 Use of nitric oxide inhibitors for treating side effects of particulate drugs |
12/22/1999 | EP0964677A1 Sustained analgesia achieved with buprenorphine |
12/22/1999 | EP0964676A1 Microparticles and their use in cancer treatment |
12/22/1999 | EP0964675A1 Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it |
12/22/1999 | EP0952770A4 System for rendering substantially non-dissoluble bio-affecting agents bio-available |
12/22/1999 | EP0748228A4 Method and device for the provocation of air passage narrowing and/or the induction of sputum |
12/22/1999 | EP0668785B1 System and method for providing a sterile medical solution containing glucose or and glucose-like compounds |
12/22/1999 | EP0661973A4 Method of preventing nmda receptor complex-mediated neuronal damage. |
12/22/1999 | CN1239436A Topical prepn. for introducing peptidaceous pharmacons in living organisms |
12/22/1999 | CN1239432A Solid pharmaceutical compsns. comprising cyclosporin and anionic surfactant |
12/22/1999 | CN1239427A Use of mupirocin for manufacture of medicament for treatment of bacterial infections associated with colonisation of nasopharynx by pathogenic organisms |
12/22/1999 | CN1239426A Pharmaceutical dosage form for colonic delivery |
12/22/1999 | CN1239425A Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
12/22/1999 | CN1239418A Transdermal/transmucosal patch dispenser |
12/22/1999 | CN1238984A Medicine for treating facial paralysis and its preparing method |
12/22/1999 | CN1238982A Chinese patent medicine for treating gastrosis |
12/22/1999 | CN1238953A Notoginseng medicine for oral application |
12/22/1999 | CN1238951A Nafiverine injection |
12/22/1999 | CN1238949A Medical plaster |
12/22/1999 | CN1238948A Making dosage units using low shear granulation |
12/22/1999 | CN1238947A Foaming medicine for treating gynopathy and preparing process thereof |
12/22/1999 | CN1238946A Liquid spray for treating oral and throat diseases and its preparing process |
12/22/1999 | CN1238944A Process for preparing powdered bath lotion from liquid one of natural plant |
12/22/1999 | CN1238943A Method for controlling sebub distribution on facial skin |